Filter by
Filter by
Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Oropharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
Published in JAMA Network Open, this retrospective study included 292 patients with nonmetastatic oropharyngeal cancer (OPC) of which 272 [93%] were HPV...
Intensity modulated proton therapy for early-stage glottic cancer: high-precision approach to laryngeal function preservation with exceptional treatment tolerability.
This study reported outcomes of 15 patients with T1-2N0 glottic cancer treated to a total dose 70 Gy. The one- and two-year OS and metastases-free survival were...
Head & Neck Cancer
Steven Frank talks about the rationale behind using proton therapy for head & neck cancers. He also presents the results of MDACC's initial experience with...
DynamicARC: the Future of Proton Therapy
DynamicARC® proton therapy is one of the most promising developments in proton radiation therapy, as it allows dynamic irradiation while the gantry is rotating...
Hypofractionation in Proton Therapy: radiobiological bases and clinical applications
The use of hypofractionated schedules in proton therapy is rapidly increasing. Their application has several advantages, including the reduction of overall...